Abbott Laboratories shares slumped Thursday after the drugmaker narrowed its full-year outlook, even as it posted better-than-expected quarterly results, as demand for COVID-19 tests declines.

Jefferies downgraded Starbucks stock from "hold" to "underperform," saying shares have "surpassed reasonable expectations." Jefferies' price target of $76 is below nearly all the targets shared with ...